{"name":"Abbisko Therapeutics Co, Ltd","slug":"abbisko-therapeutics-co-ltd","ticker":"","exchange":"","domain":"abbisko.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":11,"colorKey":"oncology","drugs":[{"name":"ABSK043 in combination with Firmonertinib","genericName":"ABSK043 in combination with Firmonertinib","slug":"absk043-in-combination-with-firmonertinib","indication":"Other","status":"phase_2"},{"name":"ABSK043 in combination with Glecirasib","genericName":"ABSK043 in combination with Glecirasib","slug":"absk043-in-combination-with-glecirasib","indication":"Other","status":"phase_2"},{"name":"ABSK043 oral capsule","genericName":"ABSK043 oral capsule","slug":"absk043-oral-capsule","indication":"Other","status":"phase_1"},{"name":"ABSK061","genericName":"ABSK061","slug":"absk061","indication":"Other","status":"phase_1"},{"name":"ABSK091 tablet","genericName":"ABSK091 tablet","slug":"absk091-tablet","indication":"Other","status":"phase_1"},{"name":"ABSK112","genericName":"ABSK112","slug":"absk112","indication":"Other","status":"phase_1"},{"name":"ABSK-011","genericName":"ABSK-011","slug":"absk-011","indication":"Other","status":"phase_2"},{"name":"ABSK021 with fasted state","genericName":"ABSK021 with fasted state","slug":"absk021-with-fasted-state","indication":"Other","status":"phase_1"},{"name":"ABSK021 with fed state","genericName":"ABSK021 with fed state","slug":"absk021-with-fed-state","indication":"Other","status":"phase_1"},{"name":"ABSK121-NX","genericName":"ABSK121-NX","slug":"absk121-nx","indication":"Other","status":"phase_1"},{"name":"ABSK131","genericName":"ABSK131","slug":"absk131","indication":"Other","status":"phase_1"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"ABSK021","genericName":"ABSK021","slug":"absk021","indication":"Metastatic non-small cell lung cancer","status":"phase_2"},{"name":"Pimicotinib(ABSK021)","genericName":"Pimicotinib(ABSK021)","slug":"pimicotinib-absk021","indication":"HER2-positive breast cancer","status":"phase_3"}]}],"pipeline":[{"name":"ABSK043 in combination with Firmonertinib","genericName":"ABSK043 in combination with Firmonertinib","slug":"absk043-in-combination-with-firmonertinib","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ABSK043 in combination with Glecirasib","genericName":"ABSK043 in combination with Glecirasib","slug":"absk043-in-combination-with-glecirasib","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ABSK043 oral capsule","genericName":"ABSK043 oral capsule","slug":"absk043-oral-capsule","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ABSK061","genericName":"ABSK061","slug":"absk061","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ABSK091 tablet","genericName":"ABSK091 tablet","slug":"absk091-tablet","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ABSK112","genericName":"ABSK112","slug":"absk112","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ABSK-011","genericName":"ABSK-011","slug":"absk-011","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ABSK021","genericName":"ABSK021","slug":"absk021","phase":"phase_2","mechanism":"ABSK021 is a small molecule targeting the PI3K/AKT/mTOR pathway.","indications":["Metastatic non-small cell lung cancer","Metastatic breast cancer"],"catalyst":""},{"name":"ABSK021 with fasted state","genericName":"ABSK021 with fasted state","slug":"absk021-with-fasted-state","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ABSK021 with fed state","genericName":"ABSK021 with fed state","slug":"absk021-with-fed-state","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ABSK121-NX","genericName":"ABSK121-NX","slug":"absk121-nx","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ABSK131","genericName":"ABSK131","slug":"absk131","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Pimicotinib(ABSK021)","genericName":"Pimicotinib(ABSK021)","slug":"pimicotinib-absk021","phase":"phase_3","mechanism":"Pimicotinib is a tyrosine kinase inhibitor that targets HER2 (human epidermal growth factor receptor 2) to inhibit cancer cell growth and proliferation.","indications":["HER2-positive breast cancer","HER2-positive gastric cancer"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxQYXNsclVnNFJkQ2tfMFBfTHJZdjI5dUJZaXJ2bThobjNPZ2loR3J2SDl4QjFOX1Itc2hPVlR4dXp4cnNNUGU0ZHNib18za2h4M1pVV2FRdUJlWUJmTHV0dDNPdGdod1djdzJ1MGZvanhHRlhJVC1jYTJrYURhUi1hUjNYR1J2MnNUNEpfY2hnTnJmX2xUNDJfdVExVklibjVDNW9XTlhnTWFOdnpxSnJEM0NNWTJlbXdsUEVDTUo4UTh5dUpOUzhZ?oc=5","date":"2026-04-01","type":"regulatory","source":"BioPharma APAC","summary":"Abbisko Therapeutics Secures EMA Orphan Drug Status For Irpagratinib In Liver Cancer - BioPharma APAC","headline":"Abbisko Therapeutics Secures EMA Orphan Drug Status For Irpagratinib In Liver Cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxQbUxZRUVlbzlTNEVLbzlmenRqOWZuRGFyNGpRSHg2SDRvaURDQldIUUVxX3VOc1dkUkpXdjZEQlR1V0dYWUlTQlZjR3QwTUVhSjgzQXhwSi1JeklobXNPMVdDMU82NzRfUEc3ZFVucjI5QXBoOVVmZ3NqbUZWMHNOWHo5NjduLWZzemhDTk0wUnI5OU5qaDZiVGpLRWZPQ0hQV2hvUXJ6MVVtMFJZeU51YVpvWTlscVE1X0Rlag?oc=5","date":"2026-03-31","type":"regulatory","source":"BioPharma APAC","summary":"Abbisko Therapeutics Secures FDA IND Clearance For ABSK061 In Achondroplasia - BioPharma APAC","headline":"Abbisko Therapeutics Secures FDA IND Clearance For ABSK061 In Achondroplasia","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxPTjFuanFnZ0lpampJc0hyMEJCNFVrWG5pYnotQ0FfNkt3ZHh0c3U1WGxNRDZRUzNVakJzUkdtWTBZa0dlRF9IX29jbW9xYWI0bm9ZdmtLWFVIdE5CRnUxa0hGNzJwclk5UFhZeldGdlRmcnQwRU5vMWFwdko4SEwxYUozbUkwN3NoNW9uTk9RVU1Oc1VTU0RKUWtlc1d4T1NmVUFWUA?oc=5","date":"2026-03-02","type":"regulatory","source":"Oncology News Central","summary":"Oncology Drugs Fast-Tracked by the FDA in February 2026 - Oncology News Central","headline":"Oncology Drugs Fast-Tracked by the FDA in February 2026","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggFBVV95cUxPYURpUDI0NUhEckszNlBmVmVKZ1dRRFczXzVmSHdVNnIybDlYMm5uNmNpdEx2bTBWWXpmVE9SNEZzZEtRMVJ1X2w2WHRUM0hVQ3VCeng5Z1BqSWNxUjJ5QkQzd0trblJjamRWUFZUQTBvRmlMMHJ1M3pud2ZkMlRxaEhB?oc=5","date":"2025-09-17","type":"deal","source":"China Daily - Global Edition","summary":"Merck aims to partner with pharma innovators - China Daily - Global Edition","headline":"Merck aims to partner with pharma innovators - China Daily","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiggJBVV95cUxQRkIyYVZHdXJ1Sl90OXNRem1xbFRtT3Q5aFJYbl9CN2lXZnl3LUxkb2diREE1Vk5JcHhCQjZQc21pa1dFc1FxYm9IUzU5N0Y0RXRMcGZLRExfakFKbHk3RlRYOXBGaWFiWDRUS09fWFFCcTBSQTR5bWN5emk3bXRnekRQd3lNYWZ0UzlreUdzTmZFcDA3ak9ZYkt2c05pOEQ2bm5iTXRXWjBLam81SFBwYXptMXdYRDk3X3BJUmQ1cEdIYm05eUJwc1NMRW9YblZfMG9yc3BPd1gxNjZDd0lkTWV5MDduSnRxQ3FnSVRVYkI0Mnk1OHNTQVFiUUl0eHlMSXc?oc=5","date":"2025-08-19","type":"pipeline","source":"prnewswire.com","summary":"FGFR Inhibitors Market Set to Surge by 2034 as Targeted Cancer Therapies Transform Treatment Paradigms | DelveInsight - prnewswire.com","headline":"FGFR Inhibitors Market Set to Surge by 2034 as Targeted Cancer Therapies Transform Treatment Paradigms | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxQY2RIZVk5Tk9sOENMVmlBeTNCYkt2b3FleXRmWlNIc3hSbE02ckc5OVZKU1BCbEZTdF95UldFaHJ2SGpNenJJTVc4c1EzRUNNTHZlUXJ0d1V0S1A4dGhTeUtQX0ZiV21IdF9VN0FoZDJ2QVVlb1o3R01WcTJPVWJsUktTelNKUHFOclN6RXpmZTVNOER6SVlmVzNfdDZDYWVEZHNJWG80NV9TcWtXX0h1X0dBbw?oc=5","date":"2025-04-01","type":"trial","source":"Fierce Biotech","summary":"Merck KGaA pays $85M to nab global rights for Abbisko's rare tumor drug after phase 3 win - Fierce Biotech","headline":"Merck KGaA pays $85M to nab global rights for Abbisko's rare tumor drug after phase 3 win","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxPczRzRm9ENm5yOW5rN0t4S18zQ0JnSEY0WjRiYjI2RjQ5eUVIeEJPdFBMUnBvR3dVNXRqSlJkZXNMMlQwNU1jZFg4STdYekplT25zZG44dXh0S3RWZUZNbkJ0VXlFTWhOSUE4cmltUEo1SWJqQ3M5VWNIY2F0dExWb3BVU2tlWFhDbkJTdjAyWEkwUQ?oc=5","date":"2025-03-28","type":"pipeline","source":"The Pharma Letter","summary":"Merck KGaA exercises option with Abbisko for pimicotinib - The Pharma Letter","headline":"Merck KGaA exercises option with Abbisko for pimicotinib","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAJBVV95cUxOSERqOXo3RmVqLWUzVzZROGdjeDdMWUJFRDFndFFuUEVKZVB1ZUFyN0trS3Q2ZkJZVC1BamQtdTBHYzlacGRqVTZIMC1tX04zc1NXV21URmlNSHlPMjMwYkozMHdacFVsNnljVURabG43YWo0bGdOSUlaNmVpZGVYWk5zZzREUDVSNFNaVVBodnQtSEdBLWRBRUNUM2ZzUldVUl85cGw2S0daYk9oLUFUQXFqdWJmdGh0d1JkTzh3anZORm5wMk5oZU55ZE5PN2FWYnBiQThGUW9waE10amtuSXMyQkYzaTdvckl3dHVQUERITlJzVmxKMnpNSDB4M1lpZ212cWQ1T3JVR2l6YVo1U3lLS3I?oc=5","date":"2025-03-04","type":"regulatory","source":"prnewswire.com","summary":"Ono's ROMVIMZA Approval Shakes Up Tenosynovial Giant Cell Tumors Market, Challenging Daiichi Sankyo's TURALIO Dominance | DelveInsight - prnewswire.com","headline":"Ono's ROMVIMZA Approval Shakes Up Tenosynovial Giant Cell Tumors Market, Challenging Daiichi Sankyo's TURALIO Dominance ","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxQRjFqTnlZMjFjM1FVNE92b2wtTVctZzdYRk9lX3FQaXFOSXFvRWhTRDN1RWx3MHJvczQ1bkhRWllJM1Z0N095eDJHWGpCdUlqUkhmRVo0OXpib1JOS3MyWG40ZF8tQWQ5MlJWQldOM0xxbUVfbWpTa3pfRlg1ekcwZThRc0N2T3VzSVRJanR1VF92WGJvOFE?oc=5","date":"2024-12-03","type":"deal","source":"Pharmaceutical Technology","summary":"Lundbeck acquires all outstanding shares of Longboard Pharma - Pharmaceutical Technology","headline":"Lundbeck acquires all outstanding shares of Longboard Pharma","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxPYW94RENDaTlVWDVGNFJVOTRYcnBaRWUzcXVDdUZWQjlMN0JQaDBETC1HWFBiQjNrZUw4bGJzUVB2OVkwdkdFUWIxeWRQb1VTRHhrRjNjNWRUMXlTcVRROEJpcjFSZ1FlalFXRzJLUjJsTmtlVnlORmpiRkFMMDctdHN1N2N3UlY0?oc=5","date":"2023-12-04","type":"pipeline","source":"pharmaphorum","summary":"Merck grabs late-stage oncology drug from China’s Abbisko - pharmaphorum","headline":"Merck grabs late-stage oncology drug from China’s Abbisko","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE9BbUxSUUQwWVJFNHhiSEljbHRQaHhVNXJmU2NnT1BrUnhSWDJIdFFIUG1EdHlmelJHbEY5eGx5aG9ZTDAwMmRqX1ZYc0J1VGpEck1SSXN4WTgyR0VBMEp6WnpGYUJOcmZpRHRlcw?oc=5","date":"2023-03-02","type":"deal","source":"팜뉴스","summary":"Abbisko Therapeutics Announces an Out-License Agreement with Allist for ABK3376 - 팜뉴스","headline":"Abbisko Therapeutics Announces an Out-License Agreement with Allist for ABK3376 - 팜뉴스","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiVkFVX3lxTFA0TGQzSWNiVVktbXJoa05XYkE0YVNldno1c2xVQW9DM2ttbE12aGJOMUk1Z3FqQ2doUmRpNEIxX1FIQVlZOFNxMFlVTUwyRWU5bzF4czBB?oc=5","date":"2021-10-17","type":"pipeline","source":"Yahoo Finance Singapore","summary":"Abbisko Cayman Limited (2256.HK) stock price, news, quote and history - Yahoo Finance Singapore","headline":"Abbisko Cayman Limited (2256.HK) stock price, news, quote and history","sentiment":"neutral"}],"patents":[],"drugCount":13,"phaseCounts":{"phase_2":4,"phase_1":8,"phase_3":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}